Aptus Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Sell |
13,887
-10,353
| -43% | -$4.61M | 0.05% | 258 |
|
|
2025
Q1 | $11.8M | Buy |
24,240
+2,072
| +9% | +$1M | 0.12% | 154 |
|
|
2024
Q4 | $8.93M | Buy |
22,168
+3,452
| +18% | +$1.39M | 0.09% | 174 |
|
|
2024
Q3 | $8.7M | Buy |
18,716
+3,071
| +20% | +$1.43M | 0.13% | 148 |
|
|
2024
Q2 | $7.33M | Buy |
15,645
+3,305
| +27% | +$1.55M | 0.13% | 142 |
|
|
2024
Q1 | $5.16M | Buy |
12,340
+10,615
| +615% | +$4.44M | 0.1% | 171 |
|
|
2023
Q4 | $702K | Sell |
1,725
-47
| -3% | -$19.1K | 0.02% | 327 |
|
|
2023
Q3 | $616K | Buy |
1,772
+698
| +65% | +$243K | 0.02% | 344 |
|
|
2023
Q2 | $378K | Buy |
1,074
+41
| +4% | +$14.4K | 0.01% | 347 |
|
|
2023
Q1 | $325K | Sell |
1,033
-333
| -24% | -$105K | 0.01% | 377 |
|
|
2022
Q4 | $394K | Buy |
1,366
+115
| +9% | +$33.2K | 0.01% | 372 |
|
|
2022
Q3 | $362K | Buy |
1,251
+229
| +22% | +$66.3K | 0.01% | 358 |
|
|
2022
Q2 | $288K | Sell |
1,022
-13
| -1% | -$3.66K | 0.01% | 323 |
|
|
2022
Q1 | $270K | Buy |
+1,035
| New | +$270K | 0.01% | 367 |
|